Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Targeting VEGF and EGFR: a combination worth re-exploring?

Tchekmedyian V, Sherman EJ.

Lancet Oncol. 2018 Jul 9. pii: S1470-2045(18)30377-2. doi: 10.1016/S1470-2045(18)30377-2. [Epub ahead of print] No abstract available.

PMID:
30001988
2.

Cetuximab-Associated Pneumatosis Intestinalis.

Sherman E, Ramadas P, Lemke S.

Am J Ther. 2018 Jun 21. doi: 10.1097/MJT.0000000000000811. [Epub ahead of print] No abstract available.

PMID:
29965806
3.

Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury.

Brooks BL, Sherman EMS.

Appl Neuropsychol Child. 2018 Jul 2:1-7. doi: 10.1080/21622965.2018.1476865. [Epub ahead of print]

PMID:
29963927
4.

Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation.

Yakovian O, Schwarzer R, Sajman J, Neve-Oz Y, Razvag Y, Herrmann A, Sherman E.

Sci Rep. 2018 Jun 27;8(1):9747. doi: 10.1038/s41598-018-28114-5.

5.

Reference samples guide variable selection for correlation of wine sensory and volatile profiling data.

Sherman E, Harbertson JF, Greenwood DR, Villas-Bôas SG, Fiehn O, Heymann H.

Food Chem. 2018 Nov 30;267:344-354. doi: 10.1016/j.foodchem.2017.10.073. Epub 2017 Oct 12.

PMID:
29934177
6.

A new kid on the block: The Memory Validity Profile (MVP) in children with neurological conditions.

Brooks BL, Fay-McClymont TB, MacAllister WS, Vasserman M, Sherman EMS.

Child Neuropsychol. 2018 Jun 6:1-12. doi: 10.1080/09297049.2018.1477929. [Epub ahead of print]

PMID:
29873604
7.

Leveraging Clinical Time-Series Data for Prediction: A Cautionary Tale.

Sherman E, Gurm H, Balis U, Owens S, Wiens J.

AMIA Annu Symp Proc. 2018 Apr 16;2017:1571-1580. eCollection 2017.

8.

Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.

Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N.

Laryngoscope. 2018 Apr 10. doi: 10.1002/lary.27191. [Epub ahead of print]

PMID:
29637571
9.

Comparison of rapid descriptive sensory methodologies: Free-Choice Profiling, Flash Profile and modified Flash Profile.

Liu J, Bredie WLP, Sherman E, Harbertson JF, Heymann H.

Food Res Int. 2018 Apr;106:892-900. doi: 10.1016/j.foodres.2018.01.062. Epub 2018 Jan 31.

PMID:
29580001
10.

Chaotization of internal motion of excitons in ultrathin layers by spin-orbit coupling.

Stephanovich VA, Sherman EY.

Phys Chem Chem Phys. 2018 Mar 14;20(11):7836-7843. doi: 10.1039/c7cp07949d.

PMID:
29505626
11.

High obsessive-compulsive individuals may have attenuated access to internal cues associated with active movement: Evidence from a head repositioning study.

Ezrati O, Sherman E, Dar R.

J Behav Ther Exp Psychiatry. 2018 Sep;60:1-4. doi: 10.1016/j.jbtep.2018.02.004. Epub 2018 Feb 16.

PMID:
29476949
12.

Patient Perceptions of Text Messaging to Improve Antiretroviral Therapy Adherence: A Qualitative Study of Patients in a Ryan White Clinic.

Sherman E, Clauson KA, Elrod S, Eckardt P, Alkhateeb F, Jacobs R.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218759209. doi: 10.1177/2325958218759209.

PMID:
29473483
13.

Nanoscale kinetic segregation of TCR and CD45 in engaged microvilli facilitates early T cell activation.

Razvag Y, Neve-Oz Y, Sajman J, Reches M, Sherman E.

Nat Commun. 2018 Feb 21;9(1):732. doi: 10.1038/s41467-018-03127-w.

14.

Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks.

Leeman JE, McBride SM, Spielsinger D, Sherman EJ, Wong R, Riaz N, Lee NY, Tsai CJ.

Int J Cancer. 2018 Jun 15;142(12):2485-2490. doi: 10.1002/ijc.31277. Epub 2018 Feb 10.

PMID:
29368332
15.

Metabolomic serum profiling after ACL injury in rats: A pilot study implicating inflammation and immune dysregulation in post-traumatic osteoarthritis.

Maerz T, Sherman E, Newton M, Yilmaz A, Kumar P, Graham SF, Baker KC.

J Orthop Res. 2018 Jan 8. doi: 10.1002/jor.23854. [Epub ahead of print]

PMID:
29315787
16.

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Dunn LA, Fury MG, Xiao H, Baxi SS, Sherman EJ, Korte S, Pfister C, Haque S, Katabi N, Ho AL, Pfister DG.

Ann Oncol. 2018 Jul 1;29(7):1606. doi: 10.1093/annonc/mdx801. No abstract available.

PMID:
29300804
17.

Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.

McCoy C, Badowski M, Sherman E, Crutchley R, Smith E, Chastain DB; Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2018 Jan;38(1):86-107. doi: 10.1002/phar.2055. Epub 2017 Dec 11. Review.

PMID:
29105160
18.

A Behavioral Economic Approach to Improving Human Papillomavirus Vaccination.

Caskey R, Sherman EG, Beskin K, Rapport R, Xia Y, Schwartz A.

J Adolesc Health. 2017 Dec;61(6):755-760. doi: 10.1016/j.jadohealth.2017.07.020. Epub 2017 Oct 14.

PMID:
29037471
19.

Validity of a Computerized Cognitive Battery in Children and Adolescents with Neurological Diagnoses.

Plourde V, Hrabok M, Sherman EMS, Brooks BL.

Arch Clin Neuropsychol. 2018 Mar 1;33(2):247-253. doi: 10.1093/arclin/acx067.

PMID:
28981565
20.

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.

Dunn LA, Fury MG, Sherman EJ, Ho AA, Katabi N, Haque SS, Pfister DG.

Head Neck. 2018 Feb;40(2):233-241. doi: 10.1002/hed.24938. Epub 2017 Sep 30.

PMID:
28963790
21.

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Dunn LA, Fury MG, Xiao H, Baxi SS, Sherman EJ, Korte S, Pfister C, Haque S, Katabi N, Ho AL, Pfister DG.

Ann Oncol. 2017 Oct 1;28(10):2533-2538. doi: 10.1093/annonc/mdx346.

PMID:
28961834
22.

Oncologist use and perception of large panel next-generation tumor sequencing.

Schram AM, Reales D, Galle J, Cambria R, Durany R, Feldman D, Sherman E, Rosenberg J, D'Andrea G, Baxi S, Janjigian Y, Tap W, Dickler M, Baselga J, Taylor BS, Chakravarty D, Gao J, Schultz N, Solit DB, Berger MF, Hyman DM.

Ann Oncol. 2017 Sep 1;28(9):2298-2304. doi: 10.1093/annonc/mdx294.

PMID:
28911072
23.

The L-type Voltage-Gated Calcium Channel co-localizes with Syntaxin 1A in nano-clusters at the plasma membrane.

Sajman J, Trus M, Atlas D, Sherman E.

Sci Rep. 2017 Sep 12;7(1):11350. doi: 10.1038/s41598-017-10588-4.

24.

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.

Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS.

Cancer. 2017 Dec 1;123(23):4583-4593. doi: 10.1002/cncr.30933. Epub 2017 Aug 17.

PMID:
28817183
25.

Highly curved image sensors: a practical approach for improved optical performance.

Guenter B, Joshi N, Stoakley R, Keefe A, Geary K, Freeman R, Hundley J, Patterson P, Hammon D, Herrera G, Sherman E, Nowak A, Schubert R, Brewer P, Yang L, Mott R, McKnight G.

Opt Express. 2017 Jun 12;25(12):13010-13023. doi: 10.1364/OE.25.013010.

PMID:
28788840
26.

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

Sherman EJ, Dunn LA, Ho AL, Baxi SS, Ghossein RA, Fury MG, Haque S, Sima CS, Cullen G, Fagin JA, Pfister DG.

Cancer. 2017 Nov 1;123(21):4114-4121. doi: 10.1002/cncr.30861. Epub 2017 Jun 29.

PMID:
28662274
27.

Resolving mixed mechanisms of protein subdiffusion at the T cell plasma membrane.

Golan Y, Sherman E.

Nat Commun. 2017 Jun 20;8:15851. doi: 10.1038/ncomms15851.

28.

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.

Leeman JE, Li JG, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, Lupovitch E, McBride SM, Tsai CJ, Boyle JO, Roman BR, Morris LGT, Dunn LA, Sherman EJ, Lee NY, Riaz N.

JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973.

PMID:
28542679
29.

Proton therapy for head and neck cancer: expanding the therapeutic window.

Leeman JE, Romesser PB, Zhou Y, McBride S, Riaz N, Sherman E, Cohen MA, Cahlon O, Lee N.

Lancet Oncol. 2017 May;18(5):e254-e265. doi: 10.1016/S1470-2045(17)30179-1. Epub 2017 Apr 26. Review.

PMID:
28456587
30.

A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry.

Drake MJ, Brennan B, Briley K Jr, Bart SM, Sherman E, Szemiel AM, Minutillo M, Bushman FD, Bates P.

PLoS Pathog. 2017 Apr 7;13(4):e1006316. doi: 10.1371/journal.ppat.1006316. eCollection 2017 Apr.

32.

INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes.

Sherman E, Nobles C, Berry CC, Six E, Wu Y, Dryga A, Malani N, Male F, Reddy S, Bailey A, Bittinger K, Everett JK, Caccavelli L, Drake MJ, Bates P, Hacein-Bey-Abina S, Cavazzana M, Bushman FD.

Mol Ther Methods Clin Dev. 2016 Dec 18;4:39-49. doi: 10.1016/j.omtm.2016.11.002. eCollection 2017 Mar 17.

33.

INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions.

Berry CC, Nobles C, Six E, Wu Y, Malani N, Sherman E, Dryga A, Everett JK, Male F, Bailey A, Bittinger K, Drake MJ, Caccavelli L, Bates P, Hacein-Bey-Abina S, Cavazzana M, Bushman FD.

Mol Ther Methods Clin Dev. 2016 Dec 18;4:17-26. doi: 10.1016/j.omtm.2016.11.003. eCollection 2017 Mar 17.

34.

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes.

Haddad RI, Schlumberger M, Wirth LJ, Sherman EJ, Shah MH, Robinson B, Dutcus CE, Teng A, Gianoukakis AG, Sherman SI.

Endocrine. 2017 Apr;56(1):121-128. doi: 10.1007/s12020-017-1233-5. Epub 2017 Feb 3.

35.

Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.

Ma J, Setton J, Morris L, Albornoz PB, Barker C, Lok BH, Sherman E, Katabi N, Beal K, Ganly I, Powell SN, Lee N, Chan TA, Riaz N.

Oncotarget. 2017 Feb 7;8(6):10312-10323. doi: 10.18632/oncotarget.14400.

36.

Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.

Zumsteg ZS, Kim S, David JM, Yoshida EJ, Tighiouart M, Shiao SL, Scher K, Mita A, Sherman EJ, Lee NY, Ho AS.

Cancer. 2017 May 1;123(9):1555-1565. doi: 10.1002/cncr.30508. Epub 2016 Dec 21.

37.

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY.

Cancer. 2017 Apr 15;123(8):1345-1353. doi: 10.1002/cncr.30495. Epub 2016 Dec 16.

38.

Development of nanoscale structure in LAT-based signaling complexes.

Barr VA, Sherman E, Yi J, Akpan I, Rouquette-Jazdanian AK, Samelson LE.

J Cell Sci. 2016 Dec 15;129(24):4548-4562. Epub 2016 Nov 10.

39.

Elvitegravir for the treatment of HIV.

Unger NR, Worley MV, Kisgen JJ, Sherman EM, Childs-Kean LM.

Expert Opin Pharmacother. 2016 Dec;17(17):2359-2370. Epub 2016 Oct 31. Review.

PMID:
27767362
40.

MCR-1 confers cross-resistance to lysozyme.

Sherman EX, Hufnagel DA, Weiss DS.

Lancet Infect Dis. 2016 Nov;16(11):1226-1227. doi: 10.1016/S1473-3099(16)30395-4. No abstract available.

PMID:
27788983
41.
42.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.

Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):687-699. doi: 10.1016/j.ijrobp.2016.08.003. Epub 2016 Aug 12.

43.

Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.

Gauthier TP, Moreira E, Chan C, Cabrera A, Toro M, Carrasquillo MZ, Corentin M, Sherman EM.

J Am Pharm Assoc (2003). 2016 Nov - Dec;56(6):670-676. doi: 10.1016/j.japh.2016.06.013. Epub 2016 Sep 22.

PMID:
27667501
44.

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Ho AL, Dunn L, Sherman EJ, Fury MG, Baxi SS, Chandramohan R, Dogan S, Morris LG, Cullen GD, Haque S, Sima CS, Ni A, Antonescu CR, Katabi N, Pfister DG.

Ann Oncol. 2016 Oct;27(10):1902-8. doi: 10.1093/annonc/mdw287. Epub 2016 Aug 26.

45.

Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.

Lee N, Schoder H, Beattie B, Lanning R, Riaz N, McBride S, Katabi N, Li D, Yarusi B, Chan S, Mitrani L, Zhang Z, Pfister DG, Sherman E, Baxi S, Boyle J, Morris LG, Ganly I, Wong R, Humm J.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):9-17. doi: 10.1016/j.ijrobp.2016.04.027. Epub 2016 May 7.

46.

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.

Brose MS, Cabanillas ME, Cohen EE, Wirth LJ, Riehl T, Yue H, Sherman SI, Sherman EJ.

Lancet Oncol. 2016 Sep;17(9):1272-82. doi: 10.1016/S1470-2045(16)30166-8. Epub 2016 Jul 23.

47.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LG, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2016 Jul 21. doi: 10.1001/jamaoncol.2016.1790. [Epub ahead of print]

48.

Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma.

Li JG, Venigalla P, Leeman JE, LaPlant Q, Setton J, Sherman E, Tsai J, McBride S, Riaz N, Lee N.

Laryngoscope. 2017 Feb;127(2):377-382. doi: 10.1002/lary.26139. Epub 2016 Jul 20.

PMID:
27438558
49.

FROM ID TO INTERSUBJECTIVITY: TALKING ABOUT THE TALKING CURE WITH MASTER CLINICIANS. By Diana T. Kenny.

Sherman E.

Psychoanal Q. 2016 Jul;85(3):811-8. doi: 10.1002/psaq.12096. Review. No abstract available.

PMID:
27428591
50.

Conformational Flexibility and Dynamics of the Internal Loop and Helical Regions of the Kink-Turn Motif in the Glycine Riboswitch by Site-Directed Spin-Labeling.

Esquiaqui JM, Sherman EM, Ye JD, Fanucci GE.

Biochemistry. 2016 Aug 9;55(31):4295-305. doi: 10.1021/acs.biochem.6b00287. Epub 2016 Jul 29.

PMID:
27427937

Supplemental Content

Loading ...
Support Center